Marshall Wace
HRMY icon

Marshall Wace’s Harmony Biosciences HRMY Stock Holding History

Marshall Wace’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.82M Buy
159,741
+10,026
+7% +$316K ﹤0.01% 1292
2026
Q1 		$4.19M Buy
149,715
+120,281
+409% +$3.94M ﹤0.01% 1385
2025
Q4 		$1.1M Sell
29,434
-255,884
-90% -$8.41M ﹤0.01% 1877
2025
Q3 		$7.86M Sell
285,318
-924,166
-76% -$31.8M 0.01% 1008
2025
Q2 		$38.2M Buy
1,209,484
+321,947
+36% +$10.4M 0.04% 366
2025
Q1 		$29.5M Sell
887,537
-42,207
-5% -$1.51M 0.04% 411
2024
Q4 		$32M Buy
929,744
+579,103
+165% +$19.9M 0.04% 402
2024
Q3 		$14M Buy
350,641
+45,029
+15% +$1.58M 0.02% 634
2024
Q2 		$9.22M Buy
305,612
+181,092
+145% +$5.45M 0.01% 769
2024
Q1 		$4.18M Buy
+124,520
New +$4M 0.01% 1068
2023
Q1 		– Sell
-162,906
Closed -$8.98M – 2853
2022
Q4 		$8.98M Buy
162,906
+141,571
+664% +$7.78M 0.02% 863
2022
Q3 		$944K Buy
+21,335
New +$1.04M ﹤0.01% 2439
2022
Q2 		– Sell
-83,961
Closed -$4.09M – 3608
2022
Q1 		$4.09M Buy
83,961
+34,974
+71% +$1.43M 0.01% 1527
2021
Q4 		$2.09M Buy
48,987
+34,098
+229% +$1.36M ﹤0.01% 2011
2021
Q3 		$570K Buy
+14,889
New +$479K ﹤0.01% 2321
2021
Q2 		– Sell
-15,545
Closed -$514K – 2820
2021
Q1 		$514K Buy
+15,545
New +$545K ﹤0.01% 1928

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marshall Wace's HRMY Position: Q2 2026 in Review

Marshall Wace increased its Harmony Biosciences (HRMY) stake by 6.7% in Q2 2026, buying an estimated $316K and bringing the position to 159,741 shares worth $5.82M. The position accounts for ﹤0.01% of the portfolio, ranked #1292.

Marshall Wace first reported a position in HRMY in Q1 2021 and has held it in 16 quarters since. The position peaked at $38.2M in Q2 2025. 327 funds tracked by Wall St. Rank hold HRMY as of Q2 2026.

  • Marshall Wace held 159,741 shares of Harmony Biosciences worth $5.82M as of Q2 2026.
  • Marshall Wace bought 10,026 Harmony Biosciences shares in Q2 2026, an estimated $316K.
  • Harmony Biosciences made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #1292 holding.
  • Marshall Wace first reported a position in Harmony Biosciences in Q1 2021 and has held it in 16 quarters since.
  • Marshall Wace's Harmony Biosciences position peaked at $38.2M in Q2 2025.
  • 327 funds tracked by Wall St. Rank held Harmony Biosciences as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.